People · Operator
Named in public records as an officer, director or promoter · active 2014–2014 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Tansna Therapeutics, Inc. | — | Biotechnology | Pre-Seed | $850K | $1.1M | — |
| Epigenetx, LLC | — | Pharmaceuticals | Pre-Seed | $170K | $8.0M | 2014 |
ALAN MACINNES at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside ALAN MACINNES on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Charles Bolten | 1 | 10 |
| Robert Beardsley | 1 | 5 |
| Max Baker | 1 | 2 |
| Robert Karr | 1 | 2 |
| Kathleen Beckmann | 1 | 1 |
| Rajesh Devraj | 1 | 1 |
| RINO RAGNO | 1 | 1 |
| GARLAND MARSHALL | 1 | 1 |
| George Capps | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.